Study on the treatment of diarrhea-predominant irritable bowel syndrome with Xifenghuashi Granules through changes in intestinal flora
- Conditions
- diarrhea-predominant irritable bowel syndrome
- Registration Number
- ITMCTR2100004795
- Lead Sponsor
- Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Conform to western medical diagnostic criteria of IBS-D;
2. Conform to diagnostic criteria of TCM syndromes of liver depression and spleen deficiency;
3. Aged 18 to 70 years, gender is not limited;
4. Subjects voluntarily participate in the trial and sign informed consent;
5. The process of obtaining informed consent should conform to ethical principles.
1. Patients with organic gastrointestinal diseases;
2. Patients with severe heart, liver, kidney, respiratory, blood, and endocrine diseases;
3. Patients with mental illness and severe neurosis;
4. Women who are pregnant, breast-feeding or planning to have a pregnancy;
5. Those who have taken antibiotics or probiotics or gastrointestinal motility drugs within 1 month before being included in the trial;
6. Patients who have poor compliance with doctor's orders or are allergic to this medicine;
7. Patients who are participating in other clinical studies.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intestinal flora;
- Secondary Outcome Measures
Name Time Method efficacy index;mental state and quality of life assessment indicators;